A focused first release for pharmaceutical teams.
Develop pharmaceutical MVPs for regulated operations, quality workflows, and process visibility with a clear path to enterprise scale.
Clear scopeReviewable deliveryPlanned handover
Start with the reason
Is this the work you need next?
An authorized reviewer needs to log a quality event, link its evidence and route it for review using agreed responsibilities.
Regulatory documentation operations
Manufacturing and supply process visibility
A useful starting scope pairs one of these needs with an accountable owner and a way to review the result.
The engagement, made tangible
Know what you are investing in.
Open a workstream to see its outputs. The proposal defines which artifacts and implementation work belong in your engagement.
Workstream 01
Pilot definition
Agree on the users and boundaries for quality-event coordination.
- Named process owner
- Pilot cohort and location
- Scope exclusions and decision criteria
Bring this into your briefDiscuss this workstream
Choose with the trade-offs visible
There is more than one way forward.
A sound recommendation depends on your constraints. The choice is explicit before it becomes an implementation assumption.
Prototype before code
Choose this when desirability or the interaction model is the main uncertainty.
What to weigh
Use the learning to narrow what needs a production build.
Pilot a working release
Choose this when real use or operational integration is necessary to test the idea.
What to weigh
Agree on a bounded cohort and the evidence needed for the next decision.
The pilot in practice
Quality-event coordination
Keep the pilot to one workflow, review it with the people who run it, and use that evidence before a wider release.
- 01
Pilot users
- 02
Quality-event coordination
- 03
Reviewed evidence
- 04
Next investment decision
How the work progresses
A decision at every milestone.
Use working evidence to review progress. Dates are agreed after scope and dependencies are understood.
Define
Agree on the problem, users, and constraints.
Decision evidence
An approved scope and acceptance criteria
Make tangible
Review the experience, contracts, or operating model.
Decision evidence
A reviewed design and dependency plan
Build and review
Implement in increments with visible progress.
Decision evidence
Working outputs checked against the scope
Release and transfer
Prepare operation, adoption, and ownership.
Decision evidence
Release approval and agreed handover assets
Quality and business value
Two questions before you call it done.
Does it behave as agreed, and is it creating the change you intended? Review both with evidence appropriate to the service.
Delivery evidence
Is the work ready?
Pilot scenarios reviewed with intended operators
Required data-access and record checks
Evidence collection and release-readiness review
Value signals
Is the change useful?
Evidence completeness
Open review age
Traceable task closure
Agree on definitions, a baseline, and a review period. These are suggested measures, not promised results.Designed for continuity
Plan the handover before the handover.
Ownership should be understandable throughout the engagement. Record the assets, access, and responsibilities your team needs after delivery.
Explore how we workProject assets
Identify source, designs, configuration, and documentation in the agreement.
Accounts and environments
Agree on account ownership, access roles, and credential handover.
Operational knowledge
Document routine tasks, recovery steps, and known limitations.
Ongoing responsibility
Define what your team owns and what support remains in scope.
Make the commercial conversation useful
What shapes the investment?
A credible estimate follows the work. These are the factors we clarify before proposing scope and delivery commitments.
01
Quality-system boundaries
Confirm during scoping02
Record and access requirements
Confirm during scoping03
Validation expectations with your quality team
Confirm during scopingBring a current system overview, representative workflows, and any fixed constraints. We can identify where discovery is needed and where a build can be estimated directly.
Request a scoped estimateHow we work together
Choose ownership, then the team.
Agree on who prioritizes work, reviews decisions, and accepts delivery. The engagement model follows that responsibility.
A defined engagement
For a bounded piece of work with clear outputs.
Agree on milestones, dependencies, and change handling.An ongoing product team
For a product or platform with a continuing roadmap.
Maintain shared priorities, review cadence, and release ownership.Embedded capability
For teams that already lead delivery and need additional expertise.
Align contributors to your engineering standards and review practices.Evaluate the people behind the promise
Bring the same scrutiny to your delivery partner.
Review published work, then ask us to connect relevant experience to your scope, constraints, and expected outcomes.
Connected work
Other pilots in this program.
Same MVP program
Logistics MVP
Launch logistics MVPs with clear operational value: shipment visibility, exception handling, and workflow automation from day one.
See this service
Same MVP programMarina & port MVP
Build marina and port MVPs that reduce operational friction across berth planning, guest workflows, and service coordination.
See this service
Same MVP programManufacturing MVP
Create manufacturing MVPs for production visibility, quality checkpoints, and operational control without overbuilding the first release.
See this service
Same MVP programRenewable energy MVP
Ship renewable energy MVPs for monitoring, asset management, and performance analytics with a roadmap for wider adoption.
See this service
Same MVP programHealthcare MVP
Build healthcare MVPs with secure workflows, operational reliability, and compliance-aware architecture from the first release.
See this service
Before you decide
Clear answers. A better brief.
What makes pharma MVP development different?
Pharma MVPs require stronger traceability and process controls from the start, so architecture and workflow decisions must account for compliance early.
Can the MVP align with future regulatory expansion?
Yes. We structure data and workflows so teams can grow reporting and compliance capabilities without rebuilding the platform core.
What pharma workflows are usually in MVP scope first?
Quality event workflows, documentation traceability, and operational visibility are common first-scope modules because they deliver immediate compliance value.
Can the pharmaceutical MVP integrate with existing ERP and QMS?
Yes. We design integration-ready architecture so ERP, QMS, and internal systems can be connected as the platform expands.
Your next move
Define the work worth doing.
Choose where you are and what to discuss. We carry that into the enquiry for Pharmaceutical MVP.